Cargando…
Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma
IMPORTANCE: High-deductible health plans (HDHPs) require high upfront cost-sharing, which has been associated with suboptimal anticancer medication uptake and adherence. Whether HDHP enrollment has limited the affordability and use of lenalidomide therapy among commercially insured patients with mul...
Autores principales: | Jazowski, Shelley A., Wilson, Lauren, Dusetzina, Stacie B., Zafar, S. Yousuf, Zullig, Leah L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175078/ https://www.ncbi.nlm.nih.gov/pubmed/35671056 http://dx.doi.org/10.1001/jamanetworkopen.2022.15720 |
Ejemplares similares
-
Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
por: Dusetzina, Stacie B., et al.
Publicado: (2021) -
Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019
por: Erath, Alexandra, et al.
Publicado: (2020) -
Utilization and Spending With Preventive Drug Lists for Asthma Medications in High-Deductible Health Plans
por: Sinaiko, Anna D., et al.
Publicado: (2023) -
Out-of-Pocket Costs Among Patients With a New Cancer Diagnosis Enrolled in High-Deductible Health Plans vs Traditional Insurance
por: Fu, Sue J., et al.
Publicado: (2021) -
Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US
por: Horný, Michal, et al.
Publicado: (2021)